Sanner appoints new CEO to drive CDMO strategy
August 11, 2025Contract Manufacturing, Manufacturing and Production CEO, Corporate, Sanner, contract development and manufacturing organisation
German packaging solutions company, Sanner, has announced a significant leadership change as it advances its transformation into a contract development …
NICE recommends treatment for rare genetic eye disorder
August 11, 2025Medical Communications Chiesi, Leber Hereditary Optic Neuropathy, NHS England, National Institute for Health and Care Excellence, Opthalmology, Rare Diseases
The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending Cheisi’s idebenone (Raxone) within its …
ARTBIO expands board and establishes technical advisory board
August 11, 2025Medical Communications, Research and Development ARTBIO, Corporate, Oncology, advisory board, radiopharmaceuticals
ARTBIO, a radiopharma company developing radioligand therapies (RLTs), has appointed four new members to its board of directors and formed …
Lilly reports positive results from trial of obesity candidate
August 8, 2025Medical Communications, Research and Development Eli Lilly and Company, Obesity, cardiovascular risk, high blood pressure, obesity
Eli Lilly and Company (Lilly) has announced topline results from its phase 3 ATTAIN-1 trial, showing that orforglipron – a …
Rollout of world-first gonorrhoea vaccine programme begins under NHS
August 8, 2025Medical Communications 10 Year Health Plan, Genito-Urinary system, Infections and infestations, NHS, gonorrhoea, sexual health, sexually transmitted infections, vaccination
From 4 August, sexual health clinics in England have been able to offer a free vaccine – the 4CMenB vaccine …
Horus Pharma expands distribution in North Africa and the Middle East
August 8, 2025Mergers and Acquisitions, Research and Development Corporate, Horus Pharma, Opthalmology, distribution agreement
Ophthalmology company, Horus Pharma, based in Nice, France, has extended its global presence through new distribution agreements across eight countries …
Aragen appoints Aniel Khubchandani as CEO of development and manufacturing solutions division
August 8, 2025Manufacturing Services, Manufacturing and Production Aragen Life Sciences, CEO, Corporate, development and manufacturing solutions, manufacturing services
Aragen Life Sciences, based in Hyderabad, India, has appointed Aniel Khubchandani as CEO of its development and manufacturing solutions (DMS) …
Faron reports increased remission rate in trial for myelodysplastic syndrome candidate
August 7, 2025Medical Communications, Research and Development Faron Pharmaceuticals, Oncology, US Food and Drug Administration, acute myeloid leukemia, myelodysplastic syndrome
Faron Pharmaceuticals has reported a rise in complete remission (CR) rates among patients with frontline high-risk myelodysplastic syndrome (HR-MDS) in …
Sanome’s AI tool gains certification for early detection of hospital infections
August 7, 2025Business Services, Research and Development AI, Devices, Infections and infestations, Medicines and Healthcare products Regulatory Agency, NHS, Sanome, hospital-acquired infections
Sanome’s MEMORI, an artificial intelligence (AI) medical device that can predict hospital-acquired infections up to 72 hours before they present, …
Cognizant launches tool to support secure AI integration in healthcare platforms
August 7, 2025Business Services, Technical Consultancy Cognizant, Devices, healthcare software
US tech solutions company, Cognizant, has launched TriZetto AI Gateway, a new tool designed to embed generative AI functions across …
PLL Therapeutics to present ALS research strategy at Bioshares Biotech Summit
August 7, 2025Medical Communications, Research and Development Bioshares Biotech Summit, Neurology, PLL Therapeutics, amyotrophic lateral sclerosis, neurodegenerative diseases
French biotech, PLL Therapeutics, will present its approach to early detection and treatment of Amyotrophic Lateral Sclerosis (ALS) at the …
MedaSystems appoints Anton White as vice president of growth
August 6, 2025Business Services Corporate, MedaSystems, vice president of growth
US software solutions company, MedaSystems, has named Anton White as vice president of growth to lead global go-to-market strategy and …
M42 study highlights positive performance of AI model for tuberculosis screening
August 6, 2025Research and Development AI, Infections and infestations, M42, X-ray, tuberculosis
Healthcare tech company, M42, has published results from one of the largest real-world studies of an artificial intelligence (AI)-powered tuberculosis …
Sanofi completes acquisition of Vigil Neuroscience to early neurology pipeline
August 6, 2025Mergers and Acquisitions Alzheimer's disease, Corporate, Neurology, Sanofi, Vigil Neuroscience, neurodegenerative diseases
Sanofi has announced that it has finalised its acquisition of Vigil Neuroscience, a US-based biotechnology company specialising in neurodegenerative diseases. …
Lilly’s drug for early Alzheimer’s shows promising results
August 6, 2025Medical Communications, Research and Development Alzheimer's, Eli Lilly, Neurology, dementia
Eli Lilly (Lilly) has announced positive new data from the long-term extension of its phase 3 study, showing that Kisunla …
FDA grants orphan drug designation to relapsed or refractory multiple myeloma candidate
August 6, 2025Medical Communications, Research and Development Oncology, Sanofi, US Food and Drug Administration, myeloma
The US Food and Drug Administration (FDA) has granted orphan drug designation to SAR446523, Sanofi’s investigational monoclonal antibody developed for …
Polpharma Biologics and Fresenius Kabi partner to develop treatment for ulcerative colitis and Crohn’s disease
August 5, 2025Mergers and Acquisitions Corporate, Crohn’s disease, Fresenius Kabi, Gastrointestinal tract, Polpharma Biologics, ulcerative colitis
Polpharma Biologics has signed a global licensing agreement with Fresenius Kabi for the commercialisation of PB016, a proposed biosimilar to …
Freya Pharma launches phase 2 study of therapy for female sexual dysfunction
August 5, 2025Research and Development Female Sexual Interest/Arousal Disorder (FSIAD), Freya Pharma Solutions, Genito-Urinary system, sexual health
Freya Pharma Solutions has announced the initiation of a phase 2 study evaluating its Lybrido to treat female sexual interest/arousal …
Advarra appoints Brian Hart as chief technology officer
August 5, 2025Business Services, Technical Consultancy Advarra, Corporate, chief technology officer, digital solutions
Digital solutions company, Advarra, has named Brian Hart as chief technology officer, strengthening its leadership team. Hart brings more than …
Hansa Biopharma announces positive data for Duchenne muscular dystrophy gene therapy
August 4, 2025Research and Development Duchenne Muscular Dystophy, Hansa Biopharma, Rare Diseases, Sarepta Therapeutics, clinical trial, genetic disorder
Hansa Biopharma has announced encouraging results from its ongoing SRP-9001-104 trial, which is investigating the use of imlifidase as a …
